Cargando…
HIV-1 Reverse Transcriptase/Integrase Dual Inhibitors: A Review of Recent Advances and Structure-activity Relationship Studies
The significant threat to humanity is HIV infection, and it is uncertain whether a definitive treatment or a safe HIV vaccine is. HIV-1 is continually evolving and resistant to commonly used HIV-resistant medications, presenting significant obstacles to HIV infection management. The drug resistance...
Autores principales: | Mahboubi-Rabbani, Mohammad, Abbasi, Maryam, Hajimahdi, Zahra, Zarghi, Afshin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457747/ https://www.ncbi.nlm.nih.gov/pubmed/34567166 http://dx.doi.org/10.22037/ijpr.2021.115446.15370 |
Ejemplares similares
-
Progress in HIV-1 Integrase Inhibitors: A Review of their Chemical Structure Diversity
por: Hajimahdi, Zahra, et al.
Publicado: (2016) -
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
por: Smith, Steven J., et al.
Publicado: (2014) -
Design, Synthesis, Docking Study, and Biological Evaluation of 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carbohydrazide Derivatives as Anti-HIV-1 and Antibacterial Agents.
por: Abdollahi, Omid, et al.
Publicado: (2022) -
Design, Synthesis, Molecular Modeling Studies and Biological Evaluation of N′-Arylidene-6-(benzyloxy)-4-oxo-1,4-dihydroquinoline-3-carbohydrazide Derivatives as Novel Anti-HCV Agents
por: Mahboubi Rabbani, Sayyed Mohammad Ismaeil, et al.
Publicado: (2019) -
HIV-1 Protease, Reverse Transcriptase, and Integrase Variation
por: Rhee, Soo-Yon, et al.
Publicado: (2016)